BMRN
Price
$56.65
Change
+$1.38 (+2.50%)
Updated
Jun 6 closing price
Capitalization
10.86B
59 days until earnings call
IONS
Price
$35.29
Change
+$0.05 (+0.14%)
Updated
Jun 6 closing price
Capitalization
5.62B
54 days until earnings call
Interact to see
Advertisement

BMRN vs IONS

Header iconBMRN vs IONS Comparison
Open Charts BMRN vs IONSBanner chart's image
BioMarin Pharmaceutical
Price$56.65
Change+$1.38 (+2.50%)
Volume$2.13M
Capitalization10.86B
Ionis Pharmaceuticals
Price$35.29
Change+$0.05 (+0.14%)
Volume$1.2M
Capitalization5.62B
BMRN vs IONS Comparison Chart
Loading...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMRN vs. IONS commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMRN is a Hold and IONS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 07, 2025
Stock price -- (BMRN: $56.65 vs. IONS: $35.29)
Brand notoriety: BMRN and IONS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMRN: 101% vs. IONS: 73%
Market capitalization -- BMRN: $10.86B vs. IONS: $5.62B
BMRN [@Biotechnology] is valued at $10.86B. IONS’s [@Biotechnology] market capitalization is $5.62B. The market cap for tickers in the [@Biotechnology] industry ranges from $324.3B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMRN’s FA Score shows that 0 FA rating(s) are green whileIONS’s FA Score has 0 green FA rating(s).

  • BMRN’s FA Score: 0 green, 5 red.
  • IONS’s FA Score: 0 green, 5 red.
According to our system of comparison, both BMRN and IONS are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMRN’s TA Score shows that 4 TA indicator(s) are bullish while IONS’s TA Score has 6 bullish TA indicator(s).

  • BMRN’s TA Score: 4 bullish, 4 bearish.
  • IONS’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IONS is a better buy in the short-term than BMRN.

Price Growth

BMRN (@Biotechnology) experienced а -2.45% price change this week, while IONS (@Biotechnology) price change was +5.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +9.04%. For the same industry, the average monthly price growth was +14.90%, and the average quarterly price growth was +1.90%.

Reported Earning Dates

BMRN is expected to report earnings on Aug 05, 2025.

IONS is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+9.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.9B) has a higher market cap than IONS($5.62B). IONS YTD gains are higher at: 0.944 vs. BMRN (-13.814). BMRN has higher annual earnings (EBITDA): 777M vs. IONS (-357.21M). IONS has more cash in the bank: 2.15B vs. BMRN (1.27B). BMRN has less debt than IONS: BMRN (602M) vs IONS (1.41B). BMRN has higher revenues than IONS: BMRN (2.95B) vs IONS (717M).
BMRNIONSBMRN / IONS
Capitalization10.9B5.62B194%
EBITDA777M-357.21M-218%
Gain YTD-13.8140.944-1,463%
P/E Ratio20.98N/A-
Revenue2.95B717M411%
Total Cash1.27B2.15B59%
Total Debt602M1.41B43%
FUNDAMENTALS RATINGS
BMRN vs IONS: Fundamental Ratings
BMRN
IONS
OUTLOOK RATING
1..100
5919
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
96
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
7096
PRICE GROWTH RATING
1..100
8452
P/E GROWTH RATING
1..100
9867
SEASONALITY SCORE
1..100
5095

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (64) in the Biotechnology industry is in the same range as IONS (96). This means that BMRN’s stock grew similarly to IONS’s over the last 12 months.

BMRN's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as IONS (100). This means that BMRN’s stock grew similarly to IONS’s over the last 12 months.

BMRN's SMR Rating (70) in the Biotechnology industry is in the same range as IONS (96). This means that BMRN’s stock grew similarly to IONS’s over the last 12 months.

IONS's Price Growth Rating (52) in the Biotechnology industry is in the same range as BMRN (84). This means that IONS’s stock grew similarly to BMRN’s over the last 12 months.

IONS's P/E Growth Rating (67) in the Biotechnology industry is in the same range as BMRN (98). This means that IONS’s stock grew similarly to BMRN’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMRNIONS
RSI
ODDS (%)
Bullish Trend 1 day ago
69%
Bearish Trend 1 day ago
81%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
64%
Bearish Trend 1 day ago
71%
Momentum
ODDS (%)
Bearish Trend 1 day ago
72%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bearish Trend 1 day ago
71%
Bullish Trend 1 day ago
67%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
65%
Bullish Trend 1 day ago
66%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
67%
Advances
ODDS (%)
Bullish Trend 18 days ago
60%
Bullish Trend 1 day ago
61%
Declines
ODDS (%)
Bearish Trend 2 days ago
62%
Bearish Trend 16 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
66%
Bearish Trend 1 day ago
89%
Aroon
ODDS (%)
Bearish Trend 1 day ago
63%
Bullish Trend 1 day ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IONS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
CONY7.900.19
+2.46%
YieldMax COIN Option Income Strategy ETF
ONOF33.330.39
+1.19%
Global X Adaptive US Risk Management ETF
GFEB38.230.21
+0.55%
FT Vest U.S. Eq Mod Buffr ETF - Feb
SHY82.21-0.14
-0.17%
iShares 1-3 Year Treasury Bond ETF
ISWN20.27-0.08
-0.38%
Amplify BlackSwan ISWN ETF

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+2.50%
ITOS - BMRN
49%
Loosely correlated
-0.10%
IBO - BMRN
46%
Loosely correlated
-5.40%
SRPT - BMRN
45%
Loosely correlated
+9.69%
IONS - BMRN
43%
Loosely correlated
+0.14%
AXON - BMRN
42%
Loosely correlated
+1.52%
More